Merck Q3 Earnings Preview: Issues That Will Dominate The Agenda (NYSE:MRK)

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?Merck & Co., Inc. (NYSE: MRK ), the New Jersey-based Pharma giant - the world's sixth largest by market cap, with a share price of $88, and market cap of $219bn (at the time of writing) - willThe group is for both ...